Cargando…
Cardiovascular hemodynamics in mice with tumor necrosis factor receptor—associated factor 2 mediated cytoprotection in the heart
INTRODUCTION: Many studies in mice have demonstrated that cardiac-specific innate immune signaling pathways can be reprogrammed to modulate inflammation in response to myocardial injury and improve outcomes. While the echocardiography standard parameters of left ventricular (LV) ejection fraction, f...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10203617/ https://www.ncbi.nlm.nih.gov/pubmed/37229235 http://dx.doi.org/10.3389/fcvm.2023.1064640 |
_version_ | 1785045675208081408 |
---|---|
author | Marshall, Andrea G. Neikirk, Kit Vue, Zer Beasley, Heather K. Garza-Lopez, Edgar Vang, Larry Barongan, Taylor Evans, Zoe Crabtree, Amber Spencer, Elsie Anudokem, Josephs Parker, Remi Davis, Jamaine Stephens, Dominique Damo, Steven Pham, Thuy T. Gomez, Jose A. Exil, Vernat Dai, Dao-fu Murray, Sandra A. Entman, Mark L. Taffet, George E. Hinton, Antentor O. Reddy, Anilkumar K. |
author_facet | Marshall, Andrea G. Neikirk, Kit Vue, Zer Beasley, Heather K. Garza-Lopez, Edgar Vang, Larry Barongan, Taylor Evans, Zoe Crabtree, Amber Spencer, Elsie Anudokem, Josephs Parker, Remi Davis, Jamaine Stephens, Dominique Damo, Steven Pham, Thuy T. Gomez, Jose A. Exil, Vernat Dai, Dao-fu Murray, Sandra A. Entman, Mark L. Taffet, George E. Hinton, Antentor O. Reddy, Anilkumar K. |
author_sort | Marshall, Andrea G. |
collection | PubMed |
description | INTRODUCTION: Many studies in mice have demonstrated that cardiac-specific innate immune signaling pathways can be reprogrammed to modulate inflammation in response to myocardial injury and improve outcomes. While the echocardiography standard parameters of left ventricular (LV) ejection fraction, fractional shortening, end-diastolic diameter, and others are used to assess cardiac function, their dependency on loading conditions somewhat limits their utility in completely reflecting the contractile function and global cardiovascular efficiency of the heart. A true measure of global cardiovascular efficiency should include the interaction between the ventricle and the aorta (ventricular-vascular coupling, VVC) as well as measures of aortic impedance and pulse wave velocity. METHODS: We measured cardiac Doppler velocities, blood pressures, along with VVC, aortic impedance, and pulse wave velocity to evaluate global cardiac function in a mouse model of cardiac-restricted low levels of TRAF2 overexpression that conferred cytoprotection in the heart. RESULTS: While previous studies reported that response to myocardial infarction and reperfusion was improved in the TRAF2 overexpressed mice, we found that TRAF2 mice had significantly lower cardiac systolic velocities and accelerations, diastolic atrial velocity, aortic pressures, rate-pressure product, LV contractility and relaxation, and stroke work when compared to littermate control mice. Also, we found significantly longer aortic ejection time, isovolumic contraction and relaxation times, and significantly higher mitral early/atrial ratio, myocardial performance index, and ventricular vascular coupling in the TRAF2 overexpression mice compared to their littermate controls. We found no significant differences in the aortic impedance and pulse wave velocity. DISCUSSION: While the reported tolerance to ischemic insults in TRAF2 overexpression mice may suggest enhanced cardiac reserve, our results indicate diminished cardiac function in these mice. |
format | Online Article Text |
id | pubmed-10203617 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-102036172023-05-24 Cardiovascular hemodynamics in mice with tumor necrosis factor receptor—associated factor 2 mediated cytoprotection in the heart Marshall, Andrea G. Neikirk, Kit Vue, Zer Beasley, Heather K. Garza-Lopez, Edgar Vang, Larry Barongan, Taylor Evans, Zoe Crabtree, Amber Spencer, Elsie Anudokem, Josephs Parker, Remi Davis, Jamaine Stephens, Dominique Damo, Steven Pham, Thuy T. Gomez, Jose A. Exil, Vernat Dai, Dao-fu Murray, Sandra A. Entman, Mark L. Taffet, George E. Hinton, Antentor O. Reddy, Anilkumar K. Front Cardiovasc Med Cardiovascular Medicine INTRODUCTION: Many studies in mice have demonstrated that cardiac-specific innate immune signaling pathways can be reprogrammed to modulate inflammation in response to myocardial injury and improve outcomes. While the echocardiography standard parameters of left ventricular (LV) ejection fraction, fractional shortening, end-diastolic diameter, and others are used to assess cardiac function, their dependency on loading conditions somewhat limits their utility in completely reflecting the contractile function and global cardiovascular efficiency of the heart. A true measure of global cardiovascular efficiency should include the interaction between the ventricle and the aorta (ventricular-vascular coupling, VVC) as well as measures of aortic impedance and pulse wave velocity. METHODS: We measured cardiac Doppler velocities, blood pressures, along with VVC, aortic impedance, and pulse wave velocity to evaluate global cardiac function in a mouse model of cardiac-restricted low levels of TRAF2 overexpression that conferred cytoprotection in the heart. RESULTS: While previous studies reported that response to myocardial infarction and reperfusion was improved in the TRAF2 overexpressed mice, we found that TRAF2 mice had significantly lower cardiac systolic velocities and accelerations, diastolic atrial velocity, aortic pressures, rate-pressure product, LV contractility and relaxation, and stroke work when compared to littermate control mice. Also, we found significantly longer aortic ejection time, isovolumic contraction and relaxation times, and significantly higher mitral early/atrial ratio, myocardial performance index, and ventricular vascular coupling in the TRAF2 overexpression mice compared to their littermate controls. We found no significant differences in the aortic impedance and pulse wave velocity. DISCUSSION: While the reported tolerance to ischemic insults in TRAF2 overexpression mice may suggest enhanced cardiac reserve, our results indicate diminished cardiac function in these mice. Frontiers Media S.A. 2023-05-09 /pmc/articles/PMC10203617/ /pubmed/37229235 http://dx.doi.org/10.3389/fcvm.2023.1064640 Text en © 2023 Marshall, Neikirk, Vue, Beasley, Garza-Lopez, Vang, Barongan, Evans, Crabtree, Spencer, Anudokem, Parker, Davis, Stephens, Damo, Pham, Gomez, Exil, Dai, Murray, Entman, Taffet, Hinton and Reddy. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) (https://creativecommons.org/licenses/by/4.0/) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Cardiovascular Medicine Marshall, Andrea G. Neikirk, Kit Vue, Zer Beasley, Heather K. Garza-Lopez, Edgar Vang, Larry Barongan, Taylor Evans, Zoe Crabtree, Amber Spencer, Elsie Anudokem, Josephs Parker, Remi Davis, Jamaine Stephens, Dominique Damo, Steven Pham, Thuy T. Gomez, Jose A. Exil, Vernat Dai, Dao-fu Murray, Sandra A. Entman, Mark L. Taffet, George E. Hinton, Antentor O. Reddy, Anilkumar K. Cardiovascular hemodynamics in mice with tumor necrosis factor receptor—associated factor 2 mediated cytoprotection in the heart |
title | Cardiovascular hemodynamics in mice with tumor necrosis factor receptor—associated factor 2 mediated cytoprotection in the heart |
title_full | Cardiovascular hemodynamics in mice with tumor necrosis factor receptor—associated factor 2 mediated cytoprotection in the heart |
title_fullStr | Cardiovascular hemodynamics in mice with tumor necrosis factor receptor—associated factor 2 mediated cytoprotection in the heart |
title_full_unstemmed | Cardiovascular hemodynamics in mice with tumor necrosis factor receptor—associated factor 2 mediated cytoprotection in the heart |
title_short | Cardiovascular hemodynamics in mice with tumor necrosis factor receptor—associated factor 2 mediated cytoprotection in the heart |
title_sort | cardiovascular hemodynamics in mice with tumor necrosis factor receptor—associated factor 2 mediated cytoprotection in the heart |
topic | Cardiovascular Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10203617/ https://www.ncbi.nlm.nih.gov/pubmed/37229235 http://dx.doi.org/10.3389/fcvm.2023.1064640 |
work_keys_str_mv | AT marshallandreag cardiovascularhemodynamicsinmicewithtumornecrosisfactorreceptorassociatedfactor2mediatedcytoprotectionintheheart AT neikirkkit cardiovascularhemodynamicsinmicewithtumornecrosisfactorreceptorassociatedfactor2mediatedcytoprotectionintheheart AT vuezer cardiovascularhemodynamicsinmicewithtumornecrosisfactorreceptorassociatedfactor2mediatedcytoprotectionintheheart AT beasleyheatherk cardiovascularhemodynamicsinmicewithtumornecrosisfactorreceptorassociatedfactor2mediatedcytoprotectionintheheart AT garzalopezedgar cardiovascularhemodynamicsinmicewithtumornecrosisfactorreceptorassociatedfactor2mediatedcytoprotectionintheheart AT vanglarry cardiovascularhemodynamicsinmicewithtumornecrosisfactorreceptorassociatedfactor2mediatedcytoprotectionintheheart AT barongantaylor cardiovascularhemodynamicsinmicewithtumornecrosisfactorreceptorassociatedfactor2mediatedcytoprotectionintheheart AT evanszoe cardiovascularhemodynamicsinmicewithtumornecrosisfactorreceptorassociatedfactor2mediatedcytoprotectionintheheart AT crabtreeamber cardiovascularhemodynamicsinmicewithtumornecrosisfactorreceptorassociatedfactor2mediatedcytoprotectionintheheart AT spencerelsie cardiovascularhemodynamicsinmicewithtumornecrosisfactorreceptorassociatedfactor2mediatedcytoprotectionintheheart AT anudokemjosephs cardiovascularhemodynamicsinmicewithtumornecrosisfactorreceptorassociatedfactor2mediatedcytoprotectionintheheart AT parkerremi cardiovascularhemodynamicsinmicewithtumornecrosisfactorreceptorassociatedfactor2mediatedcytoprotectionintheheart AT davisjamaine cardiovascularhemodynamicsinmicewithtumornecrosisfactorreceptorassociatedfactor2mediatedcytoprotectionintheheart AT stephensdominique cardiovascularhemodynamicsinmicewithtumornecrosisfactorreceptorassociatedfactor2mediatedcytoprotectionintheheart AT damosteven cardiovascularhemodynamicsinmicewithtumornecrosisfactorreceptorassociatedfactor2mediatedcytoprotectionintheheart AT phamthuyt cardiovascularhemodynamicsinmicewithtumornecrosisfactorreceptorassociatedfactor2mediatedcytoprotectionintheheart AT gomezjosea cardiovascularhemodynamicsinmicewithtumornecrosisfactorreceptorassociatedfactor2mediatedcytoprotectionintheheart AT exilvernat cardiovascularhemodynamicsinmicewithtumornecrosisfactorreceptorassociatedfactor2mediatedcytoprotectionintheheart AT daidaofu cardiovascularhemodynamicsinmicewithtumornecrosisfactorreceptorassociatedfactor2mediatedcytoprotectionintheheart AT murraysandraa cardiovascularhemodynamicsinmicewithtumornecrosisfactorreceptorassociatedfactor2mediatedcytoprotectionintheheart AT entmanmarkl cardiovascularhemodynamicsinmicewithtumornecrosisfactorreceptorassociatedfactor2mediatedcytoprotectionintheheart AT taffetgeorgee cardiovascularhemodynamicsinmicewithtumornecrosisfactorreceptorassociatedfactor2mediatedcytoprotectionintheheart AT hintonantentoro cardiovascularhemodynamicsinmicewithtumornecrosisfactorreceptorassociatedfactor2mediatedcytoprotectionintheheart AT reddyanilkumark cardiovascularhemodynamicsinmicewithtumornecrosisfactorreceptorassociatedfactor2mediatedcytoprotectionintheheart |